Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 3
2005 1
2006 3
2007 3
2008 5
2009 2
2010 2
2011 3
2012 3
2013 5
2014 4
2015 3
2016 4
2017 2
2018 1
2019 2
2020 2
2021 3
2022 4
2023 3
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial.
Niemann CU, Munir T, Moreno C, Owen C, Follows GA, Benjamini O, Janssens A, Levin MD, Robak T, Simkovic M, Voloshin S, Vorobyev V, Yagci M, Ysebaert L, Qi K, Qi Q, Sinet P, Parisi L, Srinivasan S, Schuier N, Baeten K, Howes A, Caces DB, Kater AP. Niemann CU, et al. Among authors: follows ga. Lancet Oncol. 2023 Dec;24(12):1423-1433. doi: 10.1016/S1470-2045(23)00452-7. Epub 2023 Nov 6. Lancet Oncol. 2023. PMID: 37944541 Clinical Trial.
Massive genomic rearrangement acquired in a single catastrophic event during cancer development.
Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, Pleasance ED, Lau KW, Beare D, Stebbings LA, McLaren S, Lin ML, McBride DJ, Varela I, Nik-Zainal S, Leroy C, Jia M, Menzies A, Butler AP, Teague JW, Quail MA, Burton J, Swerdlow H, Carter NP, Morsberger LA, Iacobuzio-Donahue C, Follows GA, Green AR, Flanagan AM, Stratton MR, Futreal PA, Campbell PJ. Stephens PJ, et al. Among authors: follows ga. Cell. 2011 Jan 7;144(1):27-40. doi: 10.1016/j.cell.2010.11.055. Cell. 2011. PMID: 21215367 Free PMC article.
Acalabrutinib-Obinutuzumab Improves Survival vs Chemoimmunotherapy in treatment-naive CLL in the 6-year Follow-up of ELEVATE-TN.
Sharman JP, Egyed M, Jurczak W, Skarbnik AP, Patel K, Flinn IW, Kamdar M, Munir T, Walewska R, Hughes M, Fogliato LM, Herishanu Y, Banerji V, Follows GA, Walker PA, Ghia P, Janssens AM, Byrd JC, Ferrant EF, Ferrajoli A, Wierda WG, Wachira CW, Suterwala BT, Palhares de Miranda PA, Munugalavadla V, Wun CC, Woyach JA. Sharman JP, et al. Among authors: follows ga. Blood. 2025 Apr 8:blood.2024024476. doi: 10.1182/blood.2024024476. Online ahead of print. Blood. 2025. PMID: 40198878
Transverse Leukonychia (Mees' Lines).
Follows AM, Follows GA. Follows AM, et al. Among authors: follows ga. N Engl J Med. 2023 Nov 30;389(22):e48. doi: 10.1056/NEJMicm2304533. Epub 2023 Nov 25. N Engl J Med. 2023. PMID: 38009615 No abstract available.
Platelet satellitism.
Padayatty J, Grigoropoulos N, Gilligan D, Follows GA. Padayatty J, et al. Among authors: follows ga. Eur J Haematol. 2010 Apr;84(4):366. doi: 10.1111/j.1600-0609.2009.01386.x. Epub 2009 Nov 26. Eur J Haematol. 2010. PMID: 20002169 No abstract available.
Hairy cell leukemia - immunotargets and therapies.
Basheer F, Bloxham DM, Scott MA, Follows GA. Basheer F, et al. Among authors: follows ga. Immunotargets Ther. 2014 Jun 24;3:107-20. doi: 10.2147/ITT.S31425. eCollection 2014. Immunotargets Ther. 2014. PMID: 27471703 Free PMC article. Review.
Early detection of T-cell lymphoma with T follicular helper phenotype by RHOA mutation analysis.
Dobson R, Du PY, Rásó-Barnett L, Yao WQ, Chen Z, Casa C, Ei-Daly H, Farkas L, Soilleux E, Wright P, Grant JW, Rodriguez-Justo M, Follows GA, Rashed H, Fabre M, Baxter EJ, Vassiliou G, Wotherspoon A, Attygalle AD, Liu H, Du MQ. Dobson R, et al. Among authors: follows ga. Haematologica. 2022 Feb 1;107(2):489-499. doi: 10.3324/haematol.2020.265991. Haematologica. 2022. PMID: 33567811 Free PMC article.
Assessment of fitness for bleomycin use and management of bleomycin pulmonary toxicity in patients with classical Hodgkin lymphoma: A British Society for Haematology Good Practice Paper.
Barrett A, Shah N, Chadwick A, Burns D, Burton C, Cutter DJ, Follows GA, McKay P, Osborne W, Phillips E, Wilson MR, Collins GP. Barrett A, et al. Among authors: follows ga. Br J Haematol. 2025 Jan;206(1):74-85. doi: 10.1111/bjh.19840. Epub 2024 Nov 6. Br J Haematol. 2025. PMID: 39506502 Review.
54 results